Cyclo Therapeutics, Inc. (CYTH) Financials
Stock symbol CYTH is outdated, potentially delisted? Maybe it is available on other exchange?
CYTH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 5.3 million | 18.7 million |
| June 30, 2024 | 4.7 million | 9.8 million |
| March 31, 2024 | 7.2 million | 6.6 million |
| Dec. 31, 2023 | 13.2 million | 8.5 million |
CYTH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | -12.0 million | -17812 |
| June 30, 2024 | -3.8 million | 365859 |
| March 31, 2024 | -6.2 million | 173218 |
| Dec. 31, 2023 | -4.3 million | 257771 |
CYTH Net Income
No data available :(
CYTH Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 928010 | 7143 | 27259 |
| June 30, 2024 | 1.1 million | 12376 | 285885 |
| March 31, 2024 | 3.0 million | 17507 | 665063 |
| Dec. 31, 2023 | 9.2 million | 44968 | 1.0 million |
CYTH Shares Outstanding
CYTH Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 3.8 million | 5.5 million | 2.4 million | 441 |
| June 30, 2024 | 3.8 million | 3.5 million | 1.4 million | 501 |
| March 31, 2024 | 2420 | 2.8 million | 1.6 million | 373 |
| Dec. 31, 2023 | 2420 | 4.1 million | 933034 | 1383 |
CYTH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 233772 | 16798 |
| June 30, 2024 | 123104 | 931127 |
| March 31, 2024 | 202450 | 836481 |
| Dec. 31, 2023 | 311399 | 876552 |
CYTH
Price: $0.72
52 week price:
Earnings Per Share: -0.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 140400
Market Capitalization: 23.6 million